These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 3095780)
1. [Intestinal decontamination in the neutropenic patient. Apropos of a prospective randomized study]. Pellegrin JL; Fourche J; Marit G; David B; Texier J; Reiffers J; Leng B; Broustet A Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):676-9. PubMed ID: 3095780 [TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future. Zinner SH Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995 [TBL] [Abstract][Full Text] [Related]
3. Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients. Lohner D; Debusscher L; Prévost JM; Klastersky J Cancer Treat Rep; 1979 Mar; 63(3):363-8. PubMed ID: 106963 [TBL] [Abstract][Full Text] [Related]
4. Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients. Guiot HF; van Furth R Infection; 1984; 12(1):1-4. PubMed ID: 6423548 [No Abstract] [Full Text] [Related]
5. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. Bow EJ; Rayner E; Scott BA; Louie TJ Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532 [TBL] [Abstract][Full Text] [Related]
6. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044 [TBL] [Abstract][Full Text] [Related]
7. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647 [TBL] [Abstract][Full Text] [Related]
8. [Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies]. Scaglione C; Tormena AM; Pavlovsky S Sangre (Barc); 1982; 27(5):912-8. PubMed ID: 6820192 [No Abstract] [Full Text] [Related]
9. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study). Malarme M; Meunier-Carpentier F; Klastersky J Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086 [No Abstract] [Full Text] [Related]
10. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study. Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L Infection; 1989; 17(2):65-9. PubMed ID: 2654019 [TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis with fluoroquinolones in patients with neutropenia]. Brodsky AL; Minissale CJ; Melero MJ; Sánchez Avalos JC Medicina (B Aires); 1993; 53(5):401-7. PubMed ID: 8201928 [TBL] [Abstract][Full Text] [Related]
12. The tolerability profile of prophylactic norfloxacin in neutropenic patients. Corrado ML; Struble WE; Hesney M Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S29-33. PubMed ID: 3280325 [TBL] [Abstract][Full Text] [Related]
13. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055 [TBL] [Abstract][Full Text] [Related]
14. [Limitations of selective decontamination of the digestive system in granulopenia patients toward the prevention of infection]. van der Waaij D Ned Tijdschr Geneeskd; 1985 Jul; 129(27):1268-9. PubMed ID: 3929148 [No Abstract] [Full Text] [Related]
15. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial. Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334 [TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG; Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257 [TBL] [Abstract][Full Text] [Related]
17. The value of surveillance cultures in neutropenic patients receiving selective intestinal decontamination. de Jong PJ; de Jong MD; Kuijper EJ; van der Lelie H Scand J Infect Dis; 1993; 25(1):107-13. PubMed ID: 8460334 [TBL] [Abstract][Full Text] [Related]
18. E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods. Infection; 1982; 10(3):131-8. PubMed ID: 7049955 [TBL] [Abstract][Full Text] [Related]
19. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients. Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789 [TBL] [Abstract][Full Text] [Related]